Current Practice of State-of-the-Art Surgical Coronary Revascularization

@article{Head2017CurrentPO,
  title={Current Practice of State-of-the-Art Surgical Coronary Revascularization},
  author={S. Head and M. Milojevic and D. Taggart and J. Puskas},
  journal={Circulation},
  year={2017},
  volume={136},
  pages={1331–1345}
}
Coronary artery bypass grafting remains one of the most commonly performed major surgeries, with well-established symptomatic and prognostic benefits in patients with multivessel and left main coronary artery disease. This review summarizes current indications, contemporary practice, and outcomes of coronary artery bypass grafting. Despite an increasingly higher-risk profile of patients, outcomes have significantly improved over time, with significant reductions in operative mortality and… Expand
State-of-the-Art Coronary Artery Bypass Grafting: Patient Selection, Graft Selection, and Optimizing Outcomes.
TLDR
Current evidence regarding patient selection, indications, graft selection, and potential strategies to optimize outcomes in patients treated with CABG is summarized. Expand
The Anaortic Technique with Bilateral Internal Thoracic Artery Grafting - Filling the Gap in Coronary Artery Bypass Surgery
TLDR
The adoption of off-pump CABG (OPCAB) has been shown to further decrease the risk of postoperative stroke, especially in higher-risk patients, entailing a step forward and a refinement of outcomes provided by the primeval OPCAB technique. Expand
The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week.
TLDR
The large-scale National Heart, Lung, and Blood Institute-sponsored, randomized Hybrid Trial (Hybrid Coronary Revascularization Trial) was initiated to examine whether HCR is superior to multivessel PCI, however, enrollment was suboptimal, triggering premature study discontinuation. Expand
Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI.
  • G. Stefanini, F. Alfonso, +13 authors A. Baumbach
  • Medicine
  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2020
TLDR
This Consensus Document summarizes the views on the management of myocardial revascularization failure of an expert panel of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Expand
Intraoperative predictors of favorable long-term postoperative period after arterial myocardial revascularization
TLDR
It was proved that decreased risk of combined endpoint (stroke, myocardial infarction and death) as well as improved clinical manifestations of coronary ischemia and increased ejection fraction in long-term postoperative period are associated with the use of bilateral internal thoracic artery grafting and pedicled internal thorACic artery harvesting technique. Expand
Long-term Outcomes Following Reoperative Coronary Artery Bypass Grafting.
TLDR
Reoperative CABG was not a predictor of mortality or readmission at 30-days, 1-year, and 5-years, and risk adjustment did not identify reoperative CabG as a risk factor for long-term mortality. Expand
Interventional Standby for CABG Surgery: The Reverse Paradigm.
TLDR
It has become apparent that these 2 modes of revascularization excel in distinct subsets of the population, with CABG remaining the gold standard in patients with diabetes mellitus, altered ventricular function, complex lesions, and complex lesions. Expand
Short‐ and intermediate‐term outcomes of hybrid coronary revascularization for double‐vessel disease
TLDR
Hybrid coronary revascularization for double‐vessel coronary disease is associated with similar short‐term outcomes and intermediate‐term survival as traditional coronary artery bypass grafting, and isassociated with lower transfusion requirements and a shorter length of stay than coronary arteries bypass grafts. Expand
Total Arterial Revascularization with Radial Artery and Internal Thoracic Artery T-Grafts Is Associated with Superior Long-Term Survival in Patients Undergoing Coronary Artery Bypass Grafting.
  • D. Obed, F. Fleissner, +4 authors I. Ismail
  • Medicine
  • Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
  • 2020
TLDR
Using the RA and the left ITA as T-graft is associated with a significant long-term survival benefit in patients undergoing CABG and may display a promising alternative to conventional use of a single ITA supplemented by saphenous veins. Expand
Total Arterial Revascularization with Radial Artery and Internal Thoracic Artery T-Grafts Is Associated with Superior Long-Term Survival in Patients Undergoing Coronary Artery Bypass Grafting
Aims: Compelling evidence encourages the use of the radial artery (RA) as the second arterial graft in coronary artery bypass grafting (CABG). However, its long-term benefits remain disputed. WeExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 140 REFERENCES
Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects.
TLDR
This review provides an overview on how new techniques and widespread consideration of evolving strategies have the potential to optimize outcomes after CABG and summarizes the areas that need more rigorous clinical (randomized) evaluation. Expand
Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery.
TLDR
Robotic-assisted coronary artery bypass grafting is an effective alternative to traditional coronary artery Bypass grafting for patients with single or multivessel coronary artery disease, with comparable short-term clinical and angiographic results. Expand
Long-term angiographic follow-up of robotic-assisted coronary artery revascularization.
TLDR
The long-term patency rate of grafts after robotic-assisted CABG was 92.7% at a mean follow-up period of 95.8±16.3 months, and patients consistently attained high scores on quality of life questionnaires after surgery. Expand
Hybrid revascularization for multivessel coronary artery disease.
TLDR
HCR is feasible in select patients with MVCAD referred for conventional CABG, and most of the pre-procedural characteristics were similar in the 2 groups. Expand
Radial artery conduits improve long-term survival after coronary artery bypass grafting.
TLDR
The use of two arterial conduits offers a clear and lasting survival advantage, likely due to the improved patency of RA grafts, and it is concluded that RA conduits should be more widely utilized during CABG. Expand
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.
TLDR
In a cohort of patients with ischemic cardiomyopathy, the rates of death from any cause, death from cardiovascular causes, and death fromAny cause or hospitalization for cardiovascular causes were significantly lower over 10 years among patients who underwent CABG in addition to receiving medical therapy than among those who received medical therapy alone. Expand
Off-pump versus on-pump coronary-artery bypass grafting in elderly patients.
TLDR
In patients 75 years of age or older, there was no significant difference between on-pump and off-p Pump CABG with regard to the composite outcome of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy within 30 days and within 12 months after surgery. Expand
Bilateral Internal Thoracic Artery Configuration for Coronary Artery Bypass Surgery
TLDR
Three-year systematic angiographic follow-up revealed no significant difference in graft patency between the 2 BITA configurations, however, compared with in situ configuration, the use of BITA in a Y grafting configuration results in lower rates of major adverse cardiovascular and cerebrovascular events at 7 years. Expand
Comparative effectiveness of revascularization strategies.
TLDR
It is found that, among older patients with multivessel coronary disease that did not require emergency treatment, there was a long-term survival advantage among patients who undergo CABG as compared with patients who underwent PCI. Expand
Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
TLDR
These observational data from this first multicenter study of HCR suggest that there is no significant difference in MACCE rates over 12 months between patients treated with multivessel PCI or HCR, an emerging modality. Expand
...
1
2
3
4
5
...